Pharmafile Logo
Pharmafocus logo
Advanced Search

Two products fuelling Actelion’s growth spurt

March 2, 2007
Sales and Marketing

Swiss specialist pharma company Actelion saw sales revenue rise 43% in 2006 thanks to rapid growth in its two products, …

News

US approval for Shire’s Vyvanse

February 28, 2007
Sales and Marketing

Shire and New River Pharmaceuticals have been given the green light by the FDA to market anti-ADHD drug Vyvanse. Shire, …

News

Helping UK pharma communicate

February 28, 2007
Medical Communications, Sales and Marketing HCA, assocation, public relations

The Healthcare Communications Association (HCA), which aims to promote excellence and best practice within pharmaceutical industry communications, has reached its …

Feature

Radical overhaul of NHS prescription drug prices recommended

February 20, 2007
Sales and Marketing pricing

 The Office of Fair Trading wants to reform the way prescription medicines are priced to reflect the benefits they bring …

News

Learning from Northwick Park

February 19, 2007
Research and Development UK, biotech, clinical trials, drug safety

In December 2006, the official report on the Northwick Park incident was published. Although not the end of the affair, …

Feature

Doctors attack ‘nonsensical’ NHS cost-cutting

February 19, 2007

The British Medical Association has branded as "nonsensical" the situation whereby hospitals delay routine operations because of financial problems.The doctors' …

News

Pfizer to submit evidence to NICE inquiry

February 16, 2007
Sales and Marketing

Pfizer has confirmed that it is to submit evidence to a forthcoming inquiry into the workings of NICE.The Commons Health …

News

Sanofi-Aventis growth stifled by Plavix and price cuts

February 15, 2007
Sales and Marketing

Figures show that Sanofi-Aventis continued to grow in 2006, despite its complaints about pressure in the US from generic manufacturers …

News

New HIV therapy to be fast-tracked

February 15, 2007
Research and Development

A new treatment for HIV is to be fast-tracked in Europe and the US.Pfizer's new compound maraviroc is to receive …

News

UK biotech consortium wins major grant for cutting-edge gene therapy

February 14, 2007
Research and Development

The EU has granted London-based Ark Therapeutics £1.65 million to fund research into using insect-derived viruses for producing genetic medicines.Ark …

News

UK pharma and government launch new collaboration

February 14, 2007
Research and Development

A collaboration between GlaxoSmithKline, Boehringer Ingelheim, Pfizer and East Lincolnshire PCT has been heralded as the future of healthcare in …

News

NICE set to appraise obesity treatment Accomplia

February 14, 2007
Sales and Marketing

Sanofi-Aventis' obesity treatment Acomplia (rimonabant) will be among the drugs appraised by NICE in its latest works programme. With an …

News

New anti-clotting antibody enters trials

February 12, 2007
Research and Development, Sales and Marketing

European biotech companies ThromboGenics and BioInvent are to start a phase I trial of a new drug which could prove …

News

Flexing pharma’s competitive muscles

February 12, 2007
Sales and Marketing sales, strategy

It is universally acknowledged, almost to the point of cliche, that pharmaceutical companies operate in a highly competitive environment. Ensuring …

Feature

GlaxoSmithKline plans five launches for 2007

February 9, 2007
Sales and Marketing GSK

GlaxoSmithKline is planning to launch five new products in 2007, bringing to an end a long period for the company …

News

Cholesterol drugs boost Schering-Plough

February 9, 2007
Sales and Marketing Merck, Schering-Plough

A 60% increase in sales of its cholesterol drugs franchise has helped Schering-Plough to post strong growth for 2006.Ezetrol and …

News

3,000 job losses to help AZ maintain profits and invest in R&D

February 9, 2007
Sales and Marketing AZ

AstraZeneca has indicated its plans to shed 3,000 jobs will mainly involve redundancies at its manufacturing facilities, in a renewed …

News

Momentum growing at specialists Archimedes as lead enters phase III

February 9, 2007
Research and Development

Specialist pharmaceutical company Archimedes has reached a vital stage in its plans for growth as its lead product enters phase …

News

Go-ahead for free prescriptions in Wales despite warnings

February 9, 2007
Sales and Marketing NHS, Wales

 Wales is set to abolish all NHS prescription charges to patients in a move intended to allow fairer access to …

News

Arrow purchase adds another string to AZ’s biotech bow

February 9, 2007
Research and Development

AstraZeneca has bought London-based Arrow Therapeutics for $150 million (£76 million) in cash, adding to a long list of recent …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026